Literature DB >> 10852119

Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells.

A C Saphire1, M D Bobardt, P A Gallay.   

Abstract

Our laboratory has identified a new facet of human immunodeficiency virus type 1 (HIV-1) entry. We demonstrated that the incorporation of host cyclophilin A (CypA) into nascent viruses is absolutely required for HIV-1 attachment to target cells. Although CypA is initially incorporated into the interior of the virus, we found that during maturation CypA relocates to the viral surface. Our work indicates that exposed CypA mediates HIV-1 attachment to target cells via heparans. We believe that this interaction between CypA and heparan represents the initial step in HIV-1 entry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852119     DOI: 10.1385/IR:21:2-3:211

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  25 in total

1.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A.

Authors:  M Grättinger; H Hohenberg; D Thomas; T Wilk; B Müller; H G Kräusslich
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

2.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

Review 3.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.

Authors:  I Mondor; S Ugolini; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Absconding with the chaperone: essential cyclophilin-Gag interaction in HIV-1 virions.

Authors:  J Luban
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Host cyclophilin A mediates HIV-1 attachment to target cells via heparans.

Authors:  A C Saphire; M D Bobardt; P A Gallay
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

7.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

8.  Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.

Authors:  K Wiegers; G Rutter; U Schubert; M Grättinger; H G Kräusslich
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

9.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

10.  Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction.

Authors:  M Pizzato; S A Marlow; E D Blair; Y Takeuchi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

View more
  13 in total

Review 1.  Plunder and stowaways: incorporation of cellular proteins by enveloped viruses.

Authors:  Réjean Cantin; Sylvie Méthot; Michel J Tremblay
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 2.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.

Authors:  A Tempaku; Y Maeda; W Song; S Harada
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

4.  Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection.

Authors:  Yi-Jun Zhang; Theodora Hatziioannou; Trinity Zang; Douglas Braaten; Jeremy Luban; Stephen P Goff; Paul D Bieniasz
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  SOLVx therapeutics vaccine - Activate T-cell immunity using broad surveillance epitope strategy against mutant strains SARS-COV2.

Authors:  Md Shamsuddin Sultan Khan; John A Catanzaro
Journal:  Biomed Pharmacother       Date:  2022-05-30       Impact factor: 7.419

Review 6.  SARS-CoV-2 cell entry beyond the ACE2 receptor.

Authors:  Shamila D Alipoor; Mehdi Mirsaeidi
Journal:  Mol Biol Rep       Date:  2022-06-26       Impact factor: 2.742

7.  CD147 stimulates HIV-1 infection in a signal-independent fashion.

Authors:  Tatiana Pushkarsky; Vyacheslav Yurchenko; Alicia Laborico; Michael Bukrinsky
Journal:  Biochem Biophys Res Commun       Date:  2007-09-14       Impact factor: 3.575

8.  Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.

Authors:  Wenzhang Liang; Yue Zhang; Miao Li; Fadhl Al-Shaebi; Jian Li; Jing Zhang; Lin Wei
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

9.  Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variants.

Authors:  Reshu Saxena; Sudipti Gupta; Kavita Singh; Kalyan Mitra; Anil Kumar Tripathi; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

10.  Structural and Functional Characterization of a Novel Family of Cyclophilins, the AquaCyps.

Authors:  Roman P Jakob; Philipp A M Schmidpeter; Johanna R Koch; Franz X Schmid; Timm Maier
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.